Dr. Montoya’s Stanford ME/CFS Initiative opened in 2009 with a $5 million donation. Seven years later it’s published just two studies. Is the Initiative in trouble or is it on the brink of success? Find out more in Will 2016 Finally be Montoya’s...
Lamenting the lack of a diagnostic biomarker for FM, U.S. researchers turned to measuring the expression of the genes in FM patients blood. Their findings suggested FM was a neuro-immune disease with a twist. Check out what they found in Genes Highlight Inflammation...
Is newer better? Not according to Consumer Reports which, based on cost and effectiveness criteria, picked three generic drugs over FDA approved drugs for FM patients. Check out which drugs they favored and download the report at Consumer Reports Recommends Generics...
It’s always encouraging to see established researchers from outside the chronic fatigue syndrome (ME/CFS) and fibromyalgia fields converging on them. David Systrom, a pulmonologist at Brigham and Women’s hospital in Boston, has been interested in idiopathic or...
Heath Rising recently featured two large “mega” ME/CFS projects attempting to get at the heart of ME/CFS, but they’re not the end of the very ambitious attempts underway to understand this disease. Ian Lipkin and Mady Hornig at the Center For...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.